AVR
What one share of Anteris Technologies Global holds
Orthopedic, Prosthetic and Surgical Appliances and Supplies
Anteris is a structural heart company dedicated to revolutionizing cardiac care by pioneering science-driven and measurable advancements to restore heart valve patients to healthy function. Our lead product, the DurAVR® THV System, was designed in collaboration with the world’s leading interventional cardiologists and cardiac surgeons to treat aortic stenosis — a potentially life-threatening condition resulting from a narrowing of the aortic valve.
Anteris Technologies Global’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.04 |
|---|---|
| Profit | −$1.62 |
| Capex (buildings and equipment) | $0.03 |
| Free cash flow | −$1.38 |
| Cash and investments | $2.57 |
| Debt | $0.00 |
| Book value | $2.58 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | $0.13 | −$3.77 | $0.11 | −$3.14 | — | $1.75 |
| 2025 | $0.05 | −$2.55 | $0.05 | −$2.16 | — | −$0.00 |